AnalyzeRE Revenue and Competitors
Estimated Revenue & Valuation
- AnalyzeRE's estimated annual revenue is currently $1.2M per year.
- AnalyzeRE's estimated revenue per employee is $84,000
Employee Data
- AnalyzeRE has 14 Employees.
- AnalyzeRE grew their employee count by -18% last year.
AnalyzeRE's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Engineering Manager | Reveal Email/Phone |
2 | Senior Software Engineer | Reveal Email/Phone |
3 | Software Engineer | Reveal Email/Phone |
4 | Software Engineer | Reveal Email/Phone |
AnalyzeRE Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.1M | 13 | N/A | N/A | N/A |
#2 | $1.2M | 14 | -18% | N/A | N/A |
#3 | $0.1M | 4 | -71% | $13.5M | N/A |
#4 | $2.5M | 25 | -17% | N/A | N/A |
#5 | $1.1M | 13 | 0% | N/A | N/A |
What Is AnalyzeRE?
Analyze Re is an InsurTech company that develops solutions to help uncover hidden profits within reinsurance and insurance portfolios. Reinsurers and insurers can leverage Analyze Re's real-time analytics, and artificial intelligence and machine learning–assisted technology to make faster and more informed pricing, portfolio optimization, and capital management decisions.
keywords:N/AN/A
Total Funding
14
Number of Employees
$1.2M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AnalyzeRE News
Il rapporto valuta anche le forze trainanti dietro il mercato L'ipoplasia del nervo ottico Analyzer e le dinamiche mutevoli che sono state...
C and D, ECAR (C) and OCR (D) analysis of HOXC-AS3 in breast cancer cells by the Seahorse XF24 Analyzer. E and F, Levels of intracellular...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 14 | -7% | N/A |
#2 | $0.9M | 14 | 17% | N/A |
#3 | $2.1M | 14 | 8% | N/A |
#4 | $1.7M | 14 | 27% | N/A |
#5 | N/A | 14 | -30% | N/A |